Send to a Friend Font Size: Increase Decrease

Viking Global Investors

Viking Global Investors 's Portfolio

Last Updated on 5/16/11 @ 05:55pm

Ticker	# of Shares	Price	Value
	143,085,126	$195.32	$27,947,386,811
	120,000,000	$195.32	$23,438,400,000
	75,238,700	$195.32	$14,695,622,884
GE	7,138,176	$323.11	$2,306,416,048
V	7,140,286	$317.36	$2,266,041,165
	9,798,229	$195.32	$1,913,790,089
MU	4,424,339	$370.30	$1,638,332,732
PM	9,055,492	$169.98	$1,539,252,531
	6,639,199	$195.32	$1,296,768,349
	6,524,565	$195.32	$1,274,378,036
View Additional Portfolio Information »

Viking Global Investors is a long/short equity hedge fund. The fund employs a bottom-up fundamental stock-picking strategy for its investments in equities in the U.S. and Europe. It focuses on the financial, telecommunication, media, technology, and consumer sectors. Viking Global Investors is based in New York and was founded in October, 1999 by Andreas Halvorsen, David Ott, and Brian Olson.

Messers. Halvorsen, Ott, and Olson worked together at Tiger Management Corp. All three left Tiger in early 1999.

Login to help us fill in information about this entity.

Form SCHEDULE 13G/A Oric Pharmaceuticals, Filed by: VIKING GLOBAL INVESTORS LP Aug 14, 2025 05:34PM

ORIC Pharmaceuticals Inc. (ORIC) Announces $125 Million Private Placement at $6.50/sh May 28, 2025 04:09PM

ORIC® Pharmaceuticals Announces $125 Million Private Placement Financing May 28, 2025 04:05PM

Form SCHEDULE 13G/A Oric Pharmaceuticals, Filed by: VIKING GLOBAL INVESTORS LP May 15, 2025 04:39PM

Form SC 13G Oric Pharmaceuticals, Filed by: VIKING GLOBAL INVESTORS LP Jan 30, 2024 04:31PM

Jan 22, 2024 08:30AM ORIC Pharmaceuticals (ORIC) Prices 12.5M Share Offering at $10/sh
Jan 22, 2024 08:30AM ORIC Pharmaceuticals Announces $125 Million Private Placement Financing

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed